Posts

Showing posts with the label Ofloxacin Prices

Ofloxacin Prices: During the second quarter of 2023 | ChemAnalyst

Image
For the Quarter Ending June 2023 North America Throughout the second quarter of 2023, the  pricing of Ofloxacin  in the North American region displayed a mixed trajectory. The quarter began with a continuation of the previous month's market trend, leading to a steady rise in inquiries from the domestic pharmaceutical and healthcare sectors. However, by May, Ofloxacin prices experienced a 2% decrease from the previous month. This decline was influenced by a combination of reduced demand, increased supply, and a weakening currency. The USA observed a decline in Ofloxacin prices due to heightened stocks from China and India, both major suppliers of Pharmaceutical APIs, including Ofloxacin. Furthermore, the weakening US dollar against other currencies contributed to reduced trade, making Ofloxacin more expensive for US buyers and consequently lowering demand. Despite this, prices rebounded moderately in June. Domestic Ofloxacin suppliers maintained significant inventories to meet ...

Ofloxacin Prices: Throughout the entire second quarter of 2023

Image
For the Quarter Ending June 2023 North America Within the North American region,  Ofloxacin prices  display a varied trajectory throughout the second quarter of 2023. The quarter commences in alignment with the previous month's market trend, showing a steady rise in inquiries from the domestic pharmaceutical and healthcare sector. However, May witnesses a 2% price decline compared to the prior month. This reduction can be attributed to a combination of decreased demand, increased supply, and a weakening currency, resulting in a dip in Ofloxacin prices in the USA. China and India, being significant suppliers of Pharmaceutical API including Ofloxacin, have augmented production to meet growing demands in recent months, leading to elevated stocks. Moreover, the weakening of the US dollar against other currencies has rendered Ofloxacin pricier for US buyers, further curbing demand and exerting downward pressure on prices. June sees a gradual price rebound, with domestic Ofloxacin s...